Natco Pharma Approves Letter of Offer for Rights Issue

Natco Pharma Limited's Fund Raising Committee has approved the Letter of Offer for its upcoming Rights Issue. The company has obtained ISIN: INE987B20018 for the Rights Entitlements. The issue involves up to 17,058,082 fully paid-up equity shares of face value ₹2 each, at a price of ₹750 per share, aggregating up to ₹12,794 million. This is offered on a rights basis to eligible equity shareholders in the ratio of 2 rights equity shares for every 21 fully paid-up equity shares held as of the Record Date, October 1, 2026. The Letter of Offer is being submitted to SEBI in compliance with relevant regulations.